Phase III Randomized Clinical Trial Comparing Tremelimumab With Standard-of-Care Chemotherapy in Patients With Advanced Melanoma

Por Ribas, Antoni, Kefford, Richard, Marshall, Margaret A., Punt, Cornelis J.A., Haanen, John B., Marmol, Maribel, Garbe, Claus, Gogas, Helen, Schachter, Jacob, Linette, Gerald, Lorigan, Paul, Kendra, Kari L., Maio, Michele, Trefzer, Uwe, Smylie, Michael, McArthur, Grant A., Dreno, Brigitte, Nathan, Paul D., Mackiewicz, Jacek, Kirkwood, John M., Gomez-Navarro, Jesus, Huang, Bo, Pavlov, Dmitri, Hauschild, Axel
Publicado no J Clin Oncol (2013)

Long-term Pooled Safety Analysis of Palbociclib in Combination With Endocrine Therapy for HR+/HER2- Advanced Breast Cancer

Por Diéras, Véronique, Rugo, Hope S, Schnell, Patrick, Gelmon, Karen, Cristofanilli, Massimo, Loi, Sherene, Colleoni, Marco, Lu, Dongrui R, Mori, Ave, Gauthier, Eric, Huang Bartlett, Cynthia, Slamon, Dennis J, Turner, Nicholas C, Finn, Richard S
Publicado no J Natl Cancer Inst (2018)

Efficacy results of a phase 2 trial of first-line idelalisib plus ofatumumab in chronic lymphocytic leukemia

Por Lampson, Benjamin L., Kim, Haesook T., Davids, Matthew S., Abramson, Jeremy S., Freedman, Arnold S., Jacobson, Caron A., Armand, Philippe A., Joyce, Robin M., Arnason, Jon E., Rassenti, Laura Z., Kipps, Thomas J., Fein, Joshua, Fernandes, Stacey M., Hanna, John R., Fisher, David C., Brown, Jennifer R.
Publicado no Blood Adv (2019)

Autologous Myoblasts for the Treatment of Fecal Incontinence: Results of a Phase 2 Randomized Placebo-controlled Study (MIAS)

Por Boyer, Olivier, Bridoux, Valérie, Giverne, Camille, Bisson, Aurélie, Koning, Edith, Leroi, Anne-Marie, Chambon, Pascal, Déhayes, Justine, Le Corre, Stephanie, Jacquot, Serge, Bastit, Dominique, Martinet, Jérémie, Houivet, Estelle, Tuech, Jean-Jacques, Benichou, Jacques, Michot, Francis
Publicado no Ann Surg (2018)

Pre-operative hyperfractionated concurrent radiochemotherapy for locally advanced rectal cancers: a phase II clinical study

Por Idasiak, Adam, Galwas-Kliber, Katarzyna, Behrendt, Katarzyna, Wziętek, Iwona, Kryj, Mariusz, Stobiecka, Ewa, Chmielik, Ewa, Suwiński, Rafał
Publicado no Br J Radiol (2017)

Efficacy, safety and pharmacokinetics of simeprevir and TMC647055/ritonavir with or without ribavirin and JNJ-56914845 in HCV genotype 1 infection

Por Bourgeois, Stefan, Van Vlierberghe, Hans, Moreno, Christophe, Orlent, Hans, Nevens, Frederik, Arastéh, Keikawus, Horsmans, Yves, Schattenberg, Jörn M., Buggisch, Peter, Francque, Sven, Vijgen, Leen, Kakuda, Thomas N., Hoeben, Eva, Luo, Donghan, Vandebosch, An, Jacquemyn, Bert, Van Remoortere, Pieter, Verloes, René
Publicado no BMC Gastroenterol (2017)

Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin...

Por Rahman, Ridwanur, Goyal, Vishal, Haque, Rashidul, Jamil, Kazi, Faiz, Abul, Samad, Rasheda, Ellis, Sally, Balasegaram, Manica, den Boer, Margriet, Rijal, Suman, Strub-Wourgaft, Nathalie, Alves, Fabiana, Alvar, Jorge, Sharma, Bhawna
Publicado no PLoS Negl Trop Dis (2017)

A phase I/Ib study of OTSGC-A24 combined peptide vaccine in advanced gastric cancer

Por Sundar, Raghav, Rha, Sun Young, Yamaue, Hiroki, Katsuda, Masahiro, Kono, Koji, Kim, Hyo Song, Kim, Chan, Mimura, Kousaku, Kua, Ley-Fang, Yong, Wei Peng
Publicado no BMC Cancer (2018)

Phase II study of axitinib with doublet chemotherapy in patients with advanced squamous non–small-cell lung cancer

Por Bondarenko, Igor M, Ingrosso, Antonella, Bycott, Paul, Kim, Sinil, Cebotaru, Cristina L
Publicado no BMC Cancer (2015)

A phase II trial of the nucleolin-targeted DNA aptamer AS1411 in metastatic refractory renal cell carcinoma

Por Rosenberg, Jonathan E., Bambury, Richard, Drabkin, Harry A., Lara, Primo N., Harzstark, Andrea L., Figlin, Robert A., Smith, Gregory W., Choueiri, Toni, Erlandsson, Fredrik, Laber, Damian A.
Publicado no Invest New Drugs (2013)

Phase I/II clinical trial of everolimus combined with gemcitabine/cisplatin for metastatic triple-negative breast cancer

Por Park, In Hae, Kong, Sun-Young, Kwon, Youngmee, Kim, Min Kyeong, Sim, Sung Hoon, Joo, Jungnam, Lee, Keun Seok
Publicado no J Cancer (2018)

Effectiveness of Cellulose Sulfate Vaginal Gel for the Prevention of HIV Infection: Results of a Phase III Trial in Nigeria

Por Halpern, Vera, Ogunsola, Folasade, Obunge, Orikomaba, Wang, Chin-Hua, Onyejepu, Nneka, Oduyebo, Oyinola, Taylor, Doug, McNeil, Linda, Mehta, Neha, Umo-Otong, John, Otusanya, Sakiru, Crucitti, Tania, Abdellati, Said
Publicado em 2008

A Phase II Multi‐Center Study of Bevacizumab in Combination with Ixabepilone in Subjects with Advanced Renal Cell Carcinoma

Por Burotto, Mauricio, Edgerly, Maureen, Velarde, Margarita, Balasubramaniam, Sanjeeve, Drabkin, Harry, Gormaz, Juan G., O'Sullivan, Ciara, Madan, Ravi, Fojo, Tito
Publicado no Oncologist (2017)

52-Week Efficacy and Safety of Telbivudine with Conditional Tenofovir Intensification at Week 24 in HBeAg-Positive Chronic Hepatitis B

Por Piratvisuth, Teerha, Komolmit, Piyawat, Tanwandee, Tawesak, Sukeepaisarnjaroen, Wattana, Chan, Henry L. Y., Pessôa, Mário G., Fassio, Eduardo, Ono, Suzane K., Bessone, Fernando, Daruich, Jorge, Zeuzem, Stefan, Cheinquer, Hugo, Pathan, Rashidkhan, Dong, Yuhong, Trylesinski, Aldo
Publicado em 2013

Everolimus for Previously Treated Advanced Gastric Cancer: Results of the Randomized, Double-Blind, Phase III GRANITE-1 Study

Por Ohtsu, Atsushi, Ajani, Jaffer A., Bai, Yu-Xian, Bang, Yung-Jue, Chung, Hyun-Cheol, Pan, Hong-Ming, Sahmoud, Tarek, Shen, Lin, Yeh, Kun-Huei, Chin, Keisho, Muro, Kei, Kim, Yeul Hong, Ferry, David, Tebbutt, Niall C., Al-Batran, Salah-Eddin, Smith, Heind, Costantini, Chiara, Rizvi, Syed, Lebwohl, David, Van Cutsem, Eric
Publicado no J Clin Oncol (2013)

Venetoclax plus R- or G-CHOP in non-Hodgkin lymphoma: results from the CAVALLI phase 1b trial

Por Zelenetz, Andrew D., Salles, Gilles, Mason, Kylie D., Casulo, Carla, Le Gouill, Steven, Sehn, Laurie H., Tilly, Herve, Cartron, Guillaume, Chamuleau, Martine E. D., Goy, Andre, Tam, Constantine S., Lugtenburg, Pieternella J., Petrich, Adam M., Sinha, Arijit, Samineni, Divya, Herter, Sylvia, Ingalla, Ellen, Szafer-Glusman, Edith, Klein, Christian, Sampath, Deepak, Kornacker, Martin, Mobasher, Mehrdad, Morschhauser, Franck
Publicado no Blood (2019)

Long-term donepezil use for dementia with Lewy bodies: results from an open-label extension of Phase III trial

Por Mori, Etsuro, Ikeda, Manabu, Nagai, Reiko, Matsuo, Kazutaka, Nakagawa, Masaki, Kosaka, Kenji
Publicado no Alzheimers Res Ther (2015)

The combination of elbasvir and grazoprevir for the treatment of chronic HCV infection in Japanese patients: a randomized phase II/III study

Por Kumada, Hiromitsu, Suzuki, Yoshiyuki, Karino, Yoshiyasu, Chayama, Kazuaki, Kawada, Norifumi, Okanoue, Takeshi, Itoh, Yoshito, Mochida, Satoshi, Toyoda, Hidenori, Yoshiji, Hitoshi, Takaki, Shintaro, Yatsuzuka, Naoyoshi, Yodoya, Etsuo, Iwasa, Takashi, Fujimoto, Go, Robertson, Michael N., Black, Stuart, Caro, Luzelena, Wahl, Janice
Publicado no J Gastroenterol (2016)

Examestane in advanced or recurrent endometrial carcinoma: a prospective phase II study by the Nordic Society of Gynecologic Oncology (NSGO)

Por Lindemann, Kristina, Malander, Susanne, Christensen, Rene D, Mirza, Mansoor R, Kristensen, Gunnar B, Aavall-Lundqvist, Elisabeth, Vergote, Ignace, Rosenberg, Per, Boman, Karin, Nordstrøm, Britta
Publicado em 2014

Phase II Trial Of Neoadjuvant Axitinib In Patients With Locally Advanced Non-Metastatic Clear Cell Renal Cell Carcinoma

Por Karam, Jose A., Devine, Catherine E., Urbauer, Diana L., Lozano, Marisa, Maity, Tapati, Ahrar, Kamran, Tamboli, Pheroze, Tannir, Nizar M., Wood, Christopher G.
Publicado no Eur Urol (2014)